Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference71 articles.
1. Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994–2009;Jenkins;PLoS One,2014
2. Global tuberculosis control: WHO report 2014,2015
3. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance;Wright;Lancet,2009
4. Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update,2011
5. Treatment of tuberculosis;Am J Respir Crit Care Med,2003
Cited by 199 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China;Infectious Medicine;2024-09
2. Synthetic marvels in tuberculosis research: An in-depth review of 1,3,4-oxadiazole derivatives as antitubercular agents;European Journal of Medicinal Chemistry Reports;2024-08
3. Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study;The Lancet Global Health;2024-08
4. Molecular Epidemiology of Isoniazid-resistant M tuberculosis in Port-au-Prince, Haiti;Open Forum Infectious Diseases;2024-07-18
5. Synthesis, biological activity and in silico study of alkyl eugenol derivatives as Mycobacterium tuberculosis inhibitors;Chemical Physics Impact;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3